Lipocine Inc.
LPCN
$3.09
-$0.16-4.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.19M | -2.21M | -1.86M | 1.78M | -2.22M |
| Total Depreciation and Amortization | 14.10K | 16.10K | 15.60K | 15.60K | 8.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.30K | 30.80K | 12.80K | -23.10K | -198.30K |
| Change in Net Operating Assets | 167.60K | 272.60K | -132.70K | -72.80K | -424.30K |
| Cash from Operations | -2.99M | -1.89M | -1.97M | 1.70M | -2.83M |
| Capital Expenditure | -- | -- | -- | -10.00K | -80.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 701.40K | 4.50M | -882.10K | 771.10K | 1.10M |
| Cash from Investing | 701.40K | 4.50M | -882.10K | 761.10K | 1.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 141.30K | 75.60K | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 141.30K | 75.60K | -- | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.14M | 2.69M | -2.85M | 2.46M | -1.81M |